GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
27.77
-0.72 (-2.54%)
Jun 30, 2026, 12:10 PM EDT - Market open
GH Research Market Cap
GH Research has a market cap or net worth of $1.9 billion as of June 30, 2026. Its market cap has increased by 139.37% in one year.
Market Cap
1.90B
Enterprise Value
1.69B
1-Year Change
139.37%
Ranking
Category
Stock Price
$27.77
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.90B, an increase of 135.66%. That is a compound annual growth rate of 18.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 1.90B | 141.81% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.99B |
| Viridian Therapeutics | 1.98B |
| Nuvation Bio | 1.97B |
| AtaiBeckley | 1.95B |
| Lakefront Biotherapeutics NV | 1.93B |
| Rapport Therapeutics | 1.92B |
| Sionna Therapeutics | 1.90B |
| Iovance Biotherapeutics | 1.90B |